title: Mannosyl-recognizing receptors induce an M1-like phenotype in macrophages of susceptible mice but an M2-like phenotype in mice resistant to a fungal infection.
abstract: In addition to alpha1,3 glucan, mannan and mannan-linked proteins are expressed in the outer layer of Paracoccidioides brasiliensis yeasts. The recognition of mannosyl residues by multiple pathogen recognition receptors, such as the mannose receptor (MR), complement receptor 3 (CR3) and toll-like receptor 4 (TLR4) on macrophage membranes can influence macrophage activation and the mechanisms of innate immunity against fungal pathogens. The aim of this study was to clarify the role of these receptors in the interaction between P. brasiliensis and macrophages from resistant (A/J) and susceptible (B10.A) mice. Therefore, the phagocytic, fungicidal and secretory abilities of macrophages were evaluated in the presence of mannan and antibodies against MR, CR3 and TLR4. We verified that mannan increased and anti-MR antibody decreased the killing ability and nitric oxide production of macrophages. The specific blockade of MR, CR3 and TLR4 by monoclonal antibodies impaired fungal recognition and modulated the production of cytokines. Mannan or P. brasiliensis induced decreased expression of MR and TLR2 on A/J macrophages, whereas CR3, TLR4 and TLR2 were reduced on B10.A cells. Importantly, both mannan and P. brasiliensis induced the production of IL-12 by B10.A macrophages, whereas TGF-β, TNF-α and IL-6 were produced by A/J cells. In addition, B10.A macrophages exhibited a prevalent expression of inducible NO-synthase and SOCS3 (suppressor of cytokine signaling-3), indicating a pro-inflammatory, "M1-like" differentiation. In contrast, the elevated expression of arginase-1, found in inflammatory zone-1 (FIZZ1), YM1 (CHI313, chitinase-like lectin), and SOCS1, typical markers of alternatively activated macrophages, indicates a prevalent "M2-like" differentiation of A/J macrophages. In conclusion, our data reveal that several mannosyl-recognizing receptors coordinate the apparently paradoxical innate response to paracoccidioidomycosis, in which resistance is initially mediated by alternatively activated phagocytes and tolerance to fungal growth, whereas susceptibility is linked to classically activated macrophages and the efficient control of fungal growth.
authors: Departamento de Imunologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, São Paulo, Brazil.
authors: Claudia
authors: C
authors: Feriotti
authors: Flávio V
authors: FV
authors: Loures
authors: Eliseu
authors: E
authors: Frank de Araújo
authors: Tania Alves
authors: TA
authors: da Costa
authors: Vera L G
authors: VL
authors: Calich
mesh_terms: D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology; D001119:Arginase / Q000378:metabolism; D016207:Cytokines / Q000096:biosynthesis; D003602:Cytotoxicity, Immunologic; D004198:Disease Susceptibility; D004357:Drug Synergism; D007371:Interferon-gamma / Q000494:pharmacology; D037181:Lectins, C-Type / Q000037:antagonists & inhibitors / Q000378:metabolism*; D016177:Macrophage-1 Antigen / Q000378:metabolism; D008264:Macrophages / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism*; D008351:Mannans / Q000494:pharmacology; D000090323:Mannose Receptor; D037241:Mannose-Binding Lectins / Q000037:antagonists & inhibitors / Q000378:metabolism*; D051379:Mice; D009569:Nitric Oxide / Q000096:biosynthesis; D052247:Nitric Oxide Synthase Type II / Q000378:metabolism; D010228:Paracoccidioides / Q000276:immunology*; D010229:Paracoccidioidomycosis / Q000276:immunology* / Q000378:metabolism*; D010587:Phagocytosis / Q000187:drug effects / Q000276:immunology; D010641:Phenotype; D011956:Receptors, Cell Surface / Q000037:antagonists & inhibitors / Q000378:metabolism*; D051192:Receptors, Pattern Recognition / Q000378:metabolism; D051195:Toll-Like Receptor 2 / Q000378:metabolism; D051197:Toll-Like Receptor 4 / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: D000935:Antifungal Agents; D016207:Cytokines; D037181:Lectins, C-Type; D016177:Macrophage-1 Antigen; D008351:Mannans; D000090323:Mannose Receptor; D037241:Mannose-Binding Lectins; D011956:Receptors, Cell Surface; D051192:Receptors, Pattern Recognition; D051195:Toll-Like Receptor 2; D051197:Toll-Like Receptor 4; D009569:Nitric Oxide; D007371:Interferon-gamma; D052247:Nitric Oxide Synthase Type II; C544448:Arg1 protein, mouse; D001119:Arginase
references: J Bacteriol. 1969 Mar;97(3):1036-41
references: 5776517
references: J Physiol Pharmacol. 2003 Dec;54(4):469-87
references: 14726604
references: Infect Immun. 2011 Jun;79(6):2470-80
references: 21422180
references: Immunol Rev. 2007 Oct;219:75-87
references: 17850483
references: Biochem Soc Trans. 2008 Dec;36(Pt 6):1478-81
references: 19021579
references: J Leukoc Biol. 2011 Nov;90(5):845-54
references: 21628332
references: Clin Immunol Immunopathol. 1979 Jan;12(1):21-30
references: 421371
references: Trends Microbiol. 2008 Jan;16(1):27-32
references: 18160296
references: Mol Immunol. 2010 Nov-Dec;48(1-3):26-36
references: 21035191
references: J Immunol. 2004 Dec 15;173(12):7444-53
references: 15585870
references: PLoS Pathog. 2010 Apr 22;6(4):e1000758
references: 20421940
references: Infect Immun. 1995 May;63(5):1777-83
references: 7729885
references: Med Mycol. 2011 Oct;49(7):694-703
references: 21417682
references: Br J Exp Pathol. 1985 Oct;66(5):585-94
references: 4063162
references: J Pathol. 2013 Jan;229(2):176-85
references: 23096265
references: Proc Natl Acad Sci U S A. 2007 Jan 23;104(4):1366-70
references: 17227865
references: Cell Microbiol. 2005 Apr;7(4):481-8
references: 15760448
references: Cell Microbiol. 2008 Oct;10(10):2058-66
references: 18549457
references: J Bacteriol. 1970 Feb;101(2):636-42
references: 5413832
references: Immunobiology. 2009;214(7):554-61
references: 19162368
references: Infect Immun. 1994 Apr;62(4):1494-6
references: 8132359
references: Rev Inst Med Trop Sao Paulo. 1969 May-Jun;11(3):177-81
references: 5824780
references: Curr Mol Med. 2001 Sep;1(4):469-74
references: 11899091
references: Med Mycol. 2009 Nov;47(7):722-33
references: 19888805
references: PLoS One. 2012;7(11):e51071
references: 23226464
references: Nat Rev Immunol. 2011 Apr;11(4):275-88
references: 21394104
references: J Immunol. 2007 Apr 15;178(8):4975-83
references: 17404279
references: J Clin Invest. 2006 Jun;116(6):1642-50
references: 16710478
references: Nat Rev Immunol. 2008 Dec;8(12):958-69
references: 19029990
references: J Leukoc Biol. 2011 Nov;90(5):839-41
references: 22045920
references: J Biol Chem. 2001 May 18;276(20):17497-506
references: 11297523
references: Cytokine Growth Factor Rev. 2010 Dec;21(6):405-12
references: 21075040
references: Annu Rev Immunol. 2009;27:451-83
references: 19105661
references: J Exp Med. 1983 Oct 1;158(4):1338-43
references: 6225825
references: Mycopathologia. 1990 Sep;111(3):173-80
references: 2233986
references: J Immunol. 2012 Oct 1;189(7):3439-48
references: 22925925
references: Nihon Ishinkin Gakkai Zasshi. 2002;43(3):133-6
references: 12145626
references: J Exp Med. 2002 Aug 5;196(3):407-12
references: 12163569
references: Scand J Immunol. 1977;6(8):797-807
references: 561436
references: Trends Cell Biol. 2001 Feb;11(2):66-75
references: 11166214
references: Microbes Infect. 2002 Feb;4(2):139-44
references: 11880044
references: Immunity. 2011 May 27;34(5):637-50
references: 21616434
references: Immunity. 2010 May 28;32(5):593-604
references: 20510870
references: J Immunol. 2009 Jul 15;183(2):1279-90
references: 19553529
references: Curr Pharm Des. 2006;12(32):4195-201
references: 17100622
references: J Med Vet Mycol. 1992;30(3):261-4
references: 1517962
references: Infect Immun. 1992 May;60(5):2096-100
references: 1563800
references: Infect Immun. 2010 Mar;78(3):1078-88
references: 20008536
references: Annu Rev Immunol. 1999;17:593-623
references: 10358769
references: Nucleic Acids Res. 2001 May 1;29(9):e45
references: 11328886
references: Dev Immunol. 2002 Sep;9(3):151-9
references: 12892049
references: Front Microbiol. 2011 Dec 20;2:257
references: 22194733
references: Microbes Infect. 1999 Apr;1(4):273-8
references: 10602660
references: Microbes Infect. 2004 Dec;6(15):1351-5
references: 15596119
references: J Leukoc Biol. 2008 May;83(5):1088-99
references: 18281437
references: J Immunol. 2002 May 1;168(9):4593-600
references: 11971007
references: Annu Rev Biochem. 2007;76:447-80
references: 17328678
references: Pathobiology. 1999;67(5-6):222-6
references: 10725788
references: Annu Rev Immunol. 2005;23:901-44
references: 15771589
references: Cell Immunol. 2002 Jul-Aug;218(1-2):87-94
references: 12470616
references: J Bacteriol. 1972 Apr;110(1):208-18
references: 5018021
references: Mycopathologia. 2008 Apr-May;165(4-5):223-36
references: 18777631
references: Cell Microbiol. 2005 Apr;7(4):471-9
references: 15760447
references: Front Immunol. 2012 Mar 12;3:20
references: 22566904
references: Cytokine. 2012 Apr;58(1):89-99
references: 21924922
references: FEMS Immunol Med Microbiol. 2006 Jun;47(1):56-66
references: 16706788
references: Infect Immun. 1998 Feb;66(2):800-6
references: 9453644
references: Curr Opin Immunol. 1998 Feb;10(1):50-5
references: 9523111
references: J Infect Chemother. 2008 Apr;14(2):86-92
references: 18622669